Income Statement Abpro Bio Co., Ltd.

Equities

A195990

KR7195990007

Industrial Machinery & Equipment

End-of-day quote Korea S.E. Other stock markets 2025-01-22			5-day change	1st Jan Change
404.00 ^KRW	0.00%		-5.16%	-10.22%

Jun. 16	Abpro Bio Co., Ltd. announced that it has received KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	CI
Jun. 12	Abpro Bio Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	CI

0cce84b989e36346f7c5015c.tzCmQmgq_0B-La_G6mhE7GLOdMH5M1cQNCKUqz4VDYg.gHTvOisSshkOVcGFoSsArzWmTbLIAWFfRkPM_3VEUtLeSs53XRKMLBxy7g

Published financial data: ABPRO BIO CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	31.93B	49.28B	32.91B	22.11B	25.38B
Other Revenues, Total	-	-	-	-10	-
Total Revenues	31.93B	49.28B	32.91B	22.11B	25.38B
Cost of Goods Sold, Total	44.61B	43.79B	28.99B	20.49B	24.11B
Gross Profit	-12.68B	5.49B	3.93B	1.62B	1.27B
Selling General & Admin Expenses, Total	10.22B	6.82B	7.85B	8.54B	8.27B
Provision for Bad Debts	2.23B	3.29B	-65.3M	2.57B	1.56B
R&D Expenses	1.99B	1.29B	562M	880M	573M
Depreciation & Amortization - (IS)	696M	702M	422M	563M	710M
Amortization of Goodwill and Intangible Assets - (IS)	1.99B	1.02B	60.63M	1.47M	5.24M
Other Operating Expenses	337M	415M	433M	252M	324M
Other Operating Expenses, Total	17.47B	13.54B	9.26B	12.81B	11.44B
Operating Income	-30.15B	-8.04B	-5.33B	-11.19B	-10.18B
Interest Expense, Total	-4.22B	-5.04B	-6.86B	-4.59B	-2.34B
Interest And Investment Income	538M	535M	576M	168M	302M
Net Interest Expenses	-3.68B	-4.5B	-6.28B	-4.42B	-2.04B
Income (Loss) On Equity Invest.	-	-8.77B	-5.88B	4.22B	-9.38B
Currency Exchange Gains (Loss)	307M	-1.18B	2.39B	1.76B	521M
Other Non Operating Income (Expenses)	-396M	-20.01B	8.61B	-867M	-1.01B
EBT, Excl. Unusual Items	-33.92B	-42.51B	-6.49B	-10.51B	-22.09B
Gain (Loss) On Sale Of Investments	2.57B	-4.43B	-	2.52B	16.29M
Gain (Loss) On Sale Of Assets	-58.29M	9.07M	650M	329M	-2.56B
Asset Writedown	-3.52B	-12.25B	-3.83B	-487M	-1.03B
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-34.92B	-59.18B	-9.68B	-8.14B	-25.66B
Income Tax Expense	-2.6B	2.44B	64.59M	-	84.12M
Earnings From Continuing Operations	-32.32B	-61.62B	-9.74B	-8.14B	-25.74B
Earnings Of Discontinued Operations	-5.14B	-	-775M	-	-
Net Income to Company	-37.47B	-61.62B	-10.52B	-8.14B	-25.74B
Minority Interest	1.77B	2.65B	485M	-	-
Net Income - (IS)	-35.69B	-58.97B	-10.03B	-8.14B	-25.74B
Net Income to Common Incl Extra Items	-35.69B	-58.97B	-10.03B	-8.14B	-25.74B
Net Income to Common Excl. Extra Items	-30.55B	-58.97B	-9.26B	-8.14B	-25.74B
Per Share Items
Net EPS - Basic	-273.41	-276.73	-39.85	-30.36	-92.51
Basic EPS - Continuing Operations	-234	-276.73	-36.77	-30.36	-92.51
Basic Weighted Average Shares Outstanding	131M	213M	252M	268M	278M
Net EPS - Diluted	-273.41	-292.08	-43.31	-30.36	-92.51
Diluted EPS - Continuing Operations	-234	-292.08	-40.43	-30.36	-92.51
Diluted Weighted Average Shares Outstanding	131M	214M	270M	268M	278M
Normalized Basic EPS	-148.8	-112.27	-14.19	-24.47	-49.6
Normalized Diluted EPS	-148.8	-111.65	-13.25	-24.47	-49.6
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	-25.69B	-795M	-2.71B	-9.79B	-8.31B
EBITA	-28.09B	-7.01B	-5.27B	-11.19B	-10.14B
EBIT	-30.15B	-8.04B	-5.33B	-11.19B	-10.18B
Effective Tax Rate - (Ratio)	7.45	-4.12	-0.67	-	-0.33
Normalized Net Income	-19.43B	-23.92B	-3.57B	-6.57B	-13.8B
Supplemental Operating Expense Items
Advertising Expense	-	-	-	297M	1.92M
Selling and Marketing Expenses	3.96B	1.67B	3.07B	3.54B	3.15B
General and Administrative Expenses	243M	278M	87.92M	91.04M	96.15M
Research And Development Expense From Footnotes	1.99B	1.29B	562M	880M	573M
Stock-Based Comp., SG&A Exp. (Total)	74.3M	335M	261M	-	-
Total Stock-Based Compensation	74.3M	335M	261M	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	14.96B	26.84B	53.96B	16.95B	18.86B
Short Term Investments	10.1M	-	430M	796M	944M
Trading Asset Securities, Total	-	4.04B	-	4.09B	68.36M
Total Cash And Short Term Investments	14.97B	30.89B	54.39B	21.83B	19.87B
Accounts Receivable, Total	4.16B	4.08B	2.78B	3.23B	3.99B
Other Receivables	6.27B	626M	1.41B	325M	1.04B
Notes Receivable	191M	126M	-	900M	2.83B
Total Receivables	10.62B	4.84B	4.19B	4.45B	7.87B
Inventory	16.89B	12.66B	15.19B	18.61B	16.43B
Prepaid Expenses	1B	564M	520M	40.62M	37.42M
Other Current Assets, Total	24.21B	8.86B	7.61B	857M	598M
Total Current Assets	67.69B	57.81B	81.9B	45.79B	44.8B
Gross Property Plant And Equipment	61.67B	57.44B	37.54B	37.31B	37.63B
Accumulated Depreciation	-11.93B	-17.89B	-13.37B	-14.21B	-15.06B
Net Property Plant And Equipment	49.74B	39.55B	24.17B	23.1B	22.58B
Long-term Investments	52.67B	61.66B	57.31B	79.77B	56.41B
Goodwill	6.87B	-	-	-	8B
Other Intangibles, Total	5.24B	500M	3.62B	2.39B	3.48B
Accounts Receivable Long-Term	-	-	-	-	252M
Loans Receivable Long-Term	385M	256M	32.6M	31.32M	-
Deferred Tax Assets Long-Term	3.33B	-	-	-	126M
Other Long-Term Assets, Total	3.02B	6.26B	849M	5.56B	6.45B
Total Assets	189B	166B	168B	157B	142B
Liabilities
Accounts Payable, Total	1.35B	2.23B	2.91B	1.56B	2.13B
Accrued Expenses, Total	2.07B	1.68B	479M	734M	755M
Short-term Borrowings	29.16B	2.49B	21.01B	10.2B	9.25B
Current Portion of Long-Term Debt	-	-	-	-	333M
Current Portion of Leases	174M	196M	214M	303M	367M
Current Income Taxes Payable	-	3.21M	-	-	7.35M
Other Current Liabilities	4.84B	8.23B	5.14B	3.22B	5.09B
Total Current Liabilities	37.59B	14.83B	29.76B	16.01B	17.92B
Long-Term Debt	15.11B	8.46B	-	-	1.29B
Long-Term Leases	305M	241M	583M	441M	551M
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	1.07B	-	-	-	-
Other Non Current Liabilities	3.96B	4.29B	-	10	-440
Total Liabilities	58.03B	27.83B	30.34B	16.45B	19.77B
Preferred Stock Non Redeemable	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	88.38B	126B	130B	137B	142B
Additional Paid In Capital	43.08B	83.6B	85.64B	87.29B	89.12B
Retained Earnings	-2.24B	-68.92B	-79.07B	-87.19B	-113B
Treasury Stock	-2.9M	-2.9M	-2.9M	-2.9M	-2.9M
Comprehensive Income and Other	-59.71M	-1.31B	877M	3.26B	3.82B
Total Common Equity	129B	139B	138B	140B	122B
Minority Interest	1.74B	-902M	-	-	-
Total Equity	131B	138B	138B	140B	122B
Total Liabilities And Equity	189B	166B	168B	157B	142B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	177M	251M	260M	274M	285M
ECS Total Common Shares Outstanding	177M	251M	260M	274M	285M
Book Value / Share	730.74	553.15	528.59	512.25	429.74
Tangible Book Value	117B	139B	134B	138B	111B
Tangible Book Value Per Share	662.2	551.17	514.68	503.52	389.39
Total Debt	44.75B	11.39B	21.81B	10.94B	11.79B
Net Debt	29.78B	-19.49B	-32.58B	-10.89B	-8.07B
Minority Interest, Total (Incl. Fin. Div)	1.74B	-902M	-	-	-
Equity Method Investments, Total	23.71B	49.61B	52.45B	68.58B	56.21B
Inventories - Raw Materials, Total	12B	11.41B	13.67B	16.76B	15.62B
Inventories - Work In Process, Total	295M	94.43M	500M	260M	1.4B
Inventories - Finished Goods, Total	16.86B	7.55B	7.61B	8.18B	7.32B
Inventories - Others	748M	-30	-300	370	240
Land - (BS)	15.32B	11.48B	10B	10B	10B
Buildings, Total	26.7B	26.57B	18.61B	18.49B	18.48B
Machinery, Total	18.19B	17.6B	7.22B	7.35B	7B
Accumulated Allowance for Doubtful Accounts (Supple)	4.25B	5.61B	3.47B	3.45B	3.43B

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-35.69B	-58.97B	-10.03B	-8.14B	-25.74B
Depreciation & Amortization - CF	2.41B	6.22B	2.56B	1.4B	1.84B
Amortization of Goodwill and Intangible Assets - (CF)	2.06B	1.03B	62.2M	1.47M	33.18M
Depreciation & Amortization, Total	4.46B	7.25B	2.62B	1.4B	1.87B
(Gain) Loss From Sale Of Asset	74.56M	-218M	-2.3B	-142M	79.93M
(Gain) Loss on Sale of Investments - (CF)	4.05B	975M	3.95B	-2.22B	3.24B
Asset Writedown & Restructuring Costs	1.99B	11.49B	749M	-	254M
(Income) Loss On Equity Investments - (CF)	-1.31B	13.19B	7.16B	-4.22B	9.38B
Stock-Based Compensation (CF)	74.3M	335M	261M	-	-
Provision and Write-off of Bad Debts	2.04B	1.4B	-1.21B	-17.77M	195M
Other Operating Activities, Total	2.83B	20.73B	-3.97B	6.39B	3.75B
Change In Accounts Receivable	3.74B	-1.33B	2.52B	-488M	133M
Change In Inventories	13.64B	10.9B	1.46B	-3.55B	4.68B
Change In Accounts Payable	2B	660M	568M	-1.35B	-997M
Change in Unearned Revenues	-1.52B	-2.3B	-	-	-
Change In Income Taxes	-	-	5K	-	-
Change in Other Net Operating Assets	6.3B	-1.35B	-4B	-119M	-1.7B
Cash from Operations	2.67B	2.76B	-2.22B	-12.46B	-4.86B
Capital Expenditure	-2.79B	-271M	-542M	-132M	-1.15B
Sale of Property, Plant, and Equipment	176M	637M	53.1M	5.18M	60.11M
Cash Acquisitions	-54.49B	-356M	-	-	-7.16B
Divestitures	13.51B	-	1.61B	-	-
Sale (Purchase) of Intangible assets	-152M	-383M	-3.24B	1.35B	-1.09B
Investment in Marketable and Equity Securities, Total	-26.43B	150M	-161M	-14.01B	16.42B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-6.66B	-203M	5.79B	-898M	-1.58B
Other Investing Activities, Total	-20.8B	19.23M	4.85B	-7.66B	134M
Cash from Investing	-97.63B	-406M	8.35B	-21.35B	5.63B
Short Term Debt Issued, Total	4.39B	2.6B	-	-	-
Long-Term Debt Issued, Total	46.89B	10B	14.62B	-	6.9B
Total Debt Issued	51.28B	12.6B	14.62B	-	6.9B
Short Term Debt Repaid, Total	-7.03B	-3.1B	-56.83M	-	-150M
Long-Term Debt Repaid, Total	-20.04B	-390M	-236M	-3.37B	-5.57B
Total Debt Repaid	-27.07B	-3.49B	-293M	-3.37B	-5.72B
Issuance of Common Stock	77.34B	-	5.98B	-	-
Repurchase of Common Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	1.85B	221M	-	-	-20
Cash from Financing	103B	9.33B	20.3B	-3.37B	1.18B
Foreign Exchange Rate Adjustments	-202M	476M	689M	177M	-44.09M
Miscellaneous Cash Flow Adjustments	-303M	-282M	-	-	-
Net Change in Cash	7.93B	11.88B	27.12B	-37.01B	1.9B
Supplemental Items
Cash Interest Paid	1.55B	742M	401M	398M	417M
Cash Income Tax Paid (Refund)	89.48M	24.94M	130M	-34.96M	139M
Levered Free Cash Flow	-23.16B	13.23B	-12.72B	-6.72B	-6.7B
Unlevered Free Cash Flow	-20.52B	16.37B	-8.43B	-3.85B	-5.24B
Change In Net Working Capital	3.28B	-14.47B	4.2B	-530M	-1.49B
Net Debt Issued / Repaid	24.21B	9.11B	14.32B	-3.37B	1.18B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-10.31	-2.73	-2	-4.31	-4.26
Return on Total Capital	-11.08	-3.24	-2.16	-4.51	-4.46
Return On Equity %	-26.23	-47.88	-7.06	-5.86	-19.61
Return on Common Equity	-25.88	-45.97	-6.69	-5.86	-19.61
Margin Analysis
Gross Profit Margin %	-39.71	11.15	11.93	7.32	5
SG&A Margin	32.01	13.83	23.84	38.64	32.59
EBITDA Margin %	-80.44	-1.61	-8.23	-44.28	-32.73
EBITA Margin %	-87.98	-14.23	-16.01	-50.61	-39.97
EBIT Margin %	-94.42	-16.32	-16.2	-50.62	-40.1
Income From Continuing Operations Margin %	-101.23	-125.03	-29.59	-36.83	-101.44
Net Income Margin %	-111.79	-119.66	-30.47	-36.83	-101.44
Net Avail. For Common Margin %	-95.67	-119.66	-28.12	-36.83	-101.44
Normalized Net Income Margin	-60.84	-48.55	-10.85	-29.69	-54.4
Levered Free Cash Flow Margin	-72.53	26.84	-38.64	-30.38	-26.41
Unlevered Free Cash Flow Margin	-64.28	33.23	-25.62	-17.41	-20.65
Asset Turnover
Asset Turnover	0.17	0.27	0.2	0.14	0.17
Fixed Assets Turnover	0.62	1.1	1.03	0.94	1.11
Receivables Turnover (Average Receivables)	4.05	11.95	9.59	7.36	7.03
Inventory Turnover (Average Inventory)	2.12	2.96	2.08	1.21	1.38
Short Term Liquidity
Current Ratio	1.8	3.9	2.75	2.86	2.5
Quick Ratio	0.68	2.4	1.97	1.59	1.39
Operating Cash Flow to Current Liabilities	0.07	0.19	-0.07	-0.78	-0.27
Days Sales Outstanding (Average Receivables)	90.23	30.63	38.07	49.58	51.92
Days Outstanding Inventory (Average Inventory)	172.12	123.49	175.36	301	265.29
Average Days Payable Outstanding	19.11	16.52	29.76	34.11	30.68
Cash Conversion Cycle (Average Days)	243.24	137.6	183.68	316.47	286.53
Long Term Solvency
Total Debt/Equity	34.18	8.25	15.86	7.8	9.64
Total Debt / Total Capital	25.47	7.62	13.69	7.24	8.79
LT Debt/Equity	11.77	6.3	0.42	0.31	1.51
Long-Term Debt / Total Capital	8.77